BRIANA GOODRIDGE: Open Payments
NPI 1942796206 · CRESTVIEW HILLS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 42 payments from 15 companies in 2025. Trend: 2023 $462 · 2024 $655 · 2025 $754
Food & beverage: $754
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $151 |
| Lilly USA, LLC | 4 | $93 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $76 |
| ABBVIE INC. | 4 | $72 |
| Madrigal Pharmaceuticals | 2 | $65 |
| QOL Medical, LLC | 3 | $59 |
| GENZYME CORPORATION | 2 | $53 |
| Janssen Biotech, Inc. | 2 | $40 |
| Organon LLC | 2 | $31 |
| PFIZER INC. | 1 | $21 |
Products named: ENTYVIO, OMVOH, REZDIFFRA, XIFAXAN, Sucraid, DUPIXENT, VIBERZI, TREMFYA.
Industry payments across KY — which companies pay providers there.
